CD70 as a target in cancer immunotherapy: advances, challenges, and future directions
Cancer immunotherapy represents a paradigm shift in oncology by leveraging the immune system to target tumors. The therapeutic efficacy of these approaches depends critically on identifying molecular targets that enhance treatment responses while limiting toxicity. CD70, a TNF family member, has eme...
Saved in:
| Main Authors: | Ruchen Wu, Junze Chen, Gang Wang, Lulu Han |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1609840/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CD70: An emerging target for integrated cancer diagnosis and therapy
by: Jiatao Hu, et al.
Published: (2025-07-01) -
CD70 CAR-T cells empowered by TS-2021 through ex vivo transduction show potent antitumor efficacy against glioblastoma
by: Sheng Fang, et al.
Published: (2025-06-01) -
Soluble CD27 differentially predicts resistance to anti-PD1 alone but not with anti-CTLA-4 in melanoma
by: Ikuan Sam, et al.
Published: (2025-03-01) -
Editorial: Current trends in immunotherapy: from monoclonal antibodies to CAR-T cells
by: Kishor Pant, et al.
Published: (2025-06-01) -
Cell-based immunotherapies for solid tumors: advances, challenges, and future directions
by: Ting Zhao, et al.
Published: (2025-04-01)